Skip to main content
Caplight Logo









Headsafe

Headsafe

Private
SydneyHealthcare & Life Scienceshttps://www.headsafe.com/

Last Round

Early Funding

Sep 1, 2021

Total Funding Raised

$330,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Headsafe is a medical technology company that develops portable, FDA-cleared brain assessment devices for objective concussion diagnosis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

concussion assessmentbrain injury diagnosismTBImild traumatic brain injuryportable medical deviceEEGvisual evoked potentialVEPpoint-of-care diagnosticsmedical AIbrain health techneurotechclinical decision supportsports medicine technologydigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Headsafe Comparables

Compare Headsafe with similar companies based on industry and business-model similarity.

Headsafe comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BrainScope
87%
HealthTech Connex
84%
Oculogica
82%

Headsafe Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 1, 2021
GrantJul 20, 2021
AcceleratorFeb 1, 2019

Key People

Founding team and executive leadership

Adrian Cohen

CEO and Founder

Founding Team

Craig C.

CEO HeadSafe LLC

Executive Team

Dylan Mahony

QA RA Manager, Chief Technology Officer (CTO)

Executive Team

Headsafe Investors

Notable investors and investment history

Headsafe investors
InvestorRounds
ArtesianEarly Funding
Texas Medical CenterAccelerator
Global InvestorsSeed
InvestibleSeed, Early Funding
Pacific ChannelSeed
AMGCGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 8109% MoM, reaching 2.9K.

  • May 14, 2026

    Grew 25% QoQ, from 20 to 25 employees.

Headsafe Filings

Explore SEC and related filing metadata, where available.

Headsafe filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Headsafe's valuation, stock price, and market status.

Is Headsafe a public or private company?

Headsafe is a private company.

What is the current stock price of Headsafe?

Headsafe is a private company with no public stock price. No recent secondary market data is available.

How much is Headsafe worth (valuation)?

Valuation information for Headsafe is not publicly available.

Can I buy Headsafe stock?

Headsafe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Headsafe's last funding round?

Headsafe's most recent funding round was Early Funding on September 1, 2021.

Who are the main investors in Headsafe?

Key investors in Headsafe include Artesian, Texas Medical Center, Global Investors, Investible, Pacific Channel.

Will Headsafe IPO soon?

No public IPO plans have been announced for Headsafe.

How can I track Headsafe secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Headsafe's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSydney
Employee Range22
Year Founded2013
Last FundingSep 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?